Comparison of ropivacaine versus ropivacaine + dexmedetomidine on the onset and resolution of sensory block in volunteers undergoing posterior tibial ultrasound-guided nerve sensory block

Trial Profile

Comparison of ropivacaine versus ropivacaine + dexmedetomidine on the onset and resolution of sensory block in volunteers undergoing posterior tibial ultrasound-guided nerve sensory block

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2012

At a glance

  • Drugs Dexmedetomidine (Primary) ; Ropivacaine
  • Indications Postoperative pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Aug 2012 New trial record
    • 23 Jul 2012 Results published in Anesthesia and Analgesia.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top